PBUCR - Overview: Lead/Creatinine Ratio, Random, Urine
Detecting clinically significant lead exposure, a toxic heavy metal, using random urine specimens
INSFT - Overview: Insulin, Free and Total, Serum
Assessing free (bioactive) insulin concentrations in patients with known or suspected anti-insulin antibodies
JCHAI - Overview: J-Chain Immunostain, Technical Component Only
Classification of lymphomas
KRT20 - Overview: Keratin 20 (KRT20) Immunostain, Technical Component Only
Aids in determining the primary site in carcinomas of unknown origin
KIT - Overview: KIT Immunostain, Technical Component Only
Aids in the identification of gastrointestinal stromal tumors
MUCN2 - Overview: Mucin 2, Immunostain, Technical Component Only
Aiding in subtyping intraductal papillary mucinous neoplasms
Aids in diagnosing plasma cell neoplasms
PBUOE - Overview: Lead Occupational Exposure, Random, Urine
Detecting clinically significant lead exposure due to occupational exposure This test is not a substitute for blood lead screening.
LANGR - Overview: Langerin Immunostain, Technical Component Only
Visualization of normal and neoplastic Langerhans cells
LUTHI - Overview: Luteinizing Hormone (LH) Beta Immunostain, Technical Component Only
Classification of pituitary adenomas
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.